These Are The Five Best And Worst Performing Mega-Cap Stocks In H1 2022

Published by
ValueWalk

Similar to the first quarter, the second quarter of 2022 remained tough for U.S. equities, including mega-cap stocks. Despite the aggressive monetary policies by the Fed, inflation isn’t showing any signs of slowing down, and this is hurting investors. However, investors with pharma and oil stocks in their portfolios witnessed decent gains even during the global uncertainty in the first half of 2022. On the other hand, a drop in the other mega-cap stocks provided investors with an opportunity to initiate fresh positions in these stocks at lower prices. Let’s take a look at the five best and wo…

Read More

See also  Work(out) from home: Pandemic fuels online exercise boom

Leave a Reply